This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
3/3/2026
Operator
Thank you for your continued patience. Your meeting will begin shortly.
Operator
If you need assistance at any time, please press star zero, and a member of our team will be happy to help you.
Operator
Hello and welcome everyone joining today's Arcturus Therapeutics fourth quarter in fiscal year 2025 earnings call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question and answer session. To register to ask a question at any time, please press star 1 on your telephone keypad. Please note this call is being recorded. We are standing by if you should need any assistance. And it is now my pleasure to turn the meeting over to Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations, and Marketing. Please go ahead.
You're reading a preview of the ARCT Q4 2025 earnings call.
Free account.
Disclaimer